About the Company
Big Rock Partners is a blank check company formed for the purpose of entering into a merger, stock exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. Big Rock Partners' management team includes Richard Ackerman, Chairman, President, and Chief Executive Officer, and Bennett Kim, Chief Financial Officer, Chief Investment Officer, Corporate Secretary and Director.
|Name||Ticker||Market Capitalization (USD M)||Revenue (USD M)||Price/Book||Price/Earning||Net Margin (%)|
|Conversion Labs Inc||CVLB||108548||35213||3.74||42.66||7.33|
|Royalty Pharma plc||RPRX||21578||2286||2.88||20.15||13.26|
|Organon & Co.||OGN||7323||7878||-4.52||4.82||19.26|
|Usana Health Sciences Inc||USNA||2097||1230||4.87||15.27||11.04|
|ATAI Life Sciences N.V.||ATAI||1782||20||3.94||-10.71||-821.63|
|Cronos Group Inc||CRON||1527||57||0.96||-10.58||-258.59|
|DICE Therapeutics Inc||DICE||1211||1||3.72||-30.64||None|
|NRX Pharmaceuticals Inc||NRXP||1170||2321||0.45||5.05||9.91|
|Intersect ENT Inc||XENT||894||104||56.42||-10.10||-85.02|
|Ventyx Biosciences Inc||VTYX||877||-10.72||-10.48||None|
|Phibro Animal Health Corp.||PAHC||825||853||3.49||16.77||5.70|
|Edgewise Therapeutics Inc||EWTX||793||2.79||-21.86||None|
|Phathom Pharmaceuticals Inc||PHAT||673||5.72||-4.13||None|
|Theseus Pharmaceuticals Inc||THRX||567||-12.12||-26.25||None|
|Cyteir Therapeutics Inc||CYT||548||2.80||-15.36||None|
|Rani Therapeutics Holdings Inc||RANI||514||3||9.84||-25.43||-678.00|
|Urovant Sciences Ltd||UROV||503||-3.65||-3.08||None|
|Pliant Therapeutics Inc||PLRX||475||10||2.16||-5.04||-914.12|
|Fulcrum Therapeutics Inc||FULC||472||18||2.59||-6.30||-409.62|
|Ikena Oncology Inc||IKNA||465||11||2.28||-7.38||-581.21|
|Provention Bio Inc||PRVB||399||1||3.08||-3.27||None|
|Rain Therapeutics Inc||RAIN||350||413||2.42||-9.15||123.20|
|Adicet Bio Inc||ACET||279||10||1.52||4.84||-570.14|
|Verrica Pharmaceuticals Inc||VRCA||241||12||6.26||-6.30||-320.98|
|Milestone Pharmaceuticals Inc||MIST||231||15||1.32||-7.52||-230.90|
|Aquestive Therapeutics Inc||AQST||194||47||-3.59||-3.11||-132.11|
|Terns Pharmaceuticals Inc||TERN||193||1.13||-5.54||None|
|Cognition Therapeutics Inc||CGTX||185||-2.24||-15.75||None|
|Opiant Pharmaceuticals Inc||OPNT||150||44||3.37||120.00||3.58|
|Anebulo Pharmaceuticals Inc||ANEB||149||7.62||-3.81||None|
|Citius Pharmaceuticals Inc||CTXR||134||1.68||-5.85||None|
|Kaleido Biosciences Inc||KLDO||132||1||4.80||-1.48||None|
|Xeris Biopharma Holdings Inc||XERS||124||35||-100.00||-1.36||-265.78|
|Kala Pharmaceuticals Inc||KALA||107||12||1.84||-0.85||None|
|Aerpio Pharmaceuticals Inc||ARPO||99||15||2.98||-5.24||-28.77|
|Eton Pharmaceuticals Inc||ETON||92||16||5.75||-8.36||-67.52|
|Natural Alternatives Internati||NAII||78||177||0.97||6.99||6.64|
|Osmotica Pharmaceuticals Plc||OSMT||76||166||1.83||-0.75||-60.32|
|Odonate Therapeutics Inc||ODT||58||0.83||-0.57||None|
|India Globalization Capital In||IGC||58||0||2.05||-5.00||-981.18|
|Context Therapeutics Inc||CNTX||57||-2.81||-8.19||None|
|Assertio Holdings Inc||ASRT||55||108||0.65||-1.32||-28.04|
|VYNE Therapeutics Inc||VYNE||46||17||0.85||-0.83||-507.13|
|Reviva Pharmaceuticals Holding||RVPH||39||1.52||-4.50||None|
|Acasti Pharma Inc||ACST||29||0||0.47||-2.16||-611.47|
|Bio-Path Holdings Inc||BPTH||25||0||1.02||-2.73||18.96|
|Nabriva Therapeutics Plc||NBRV||23||20||0.63||-0.37||-266.57|
|Baudax Bio Inc||BXRX||21||1||-1.35||-0.45||9.10|
|Lexaria Bioscience Corp||LEXX||20||1||2.76||-5.10||-445.15|
|Dermata Therapeutics Inc||DRMA||20||0.45||-2.46||None|
|Trevi Therapeutics Inc||TRVI||19||2.16||-0.54||None|
|Hoth Therapeutics Inc||HOTH||16||1.45||-1.50||None|
|Timber Pharmaceuticals Inc||TMBR||13||0||11.00||3.07||-527.55|
|Sonoma Pharmaceuticals Inc.||SNOA||9||17||3.02||-1.72||-31.96|
NRX Pharmaceuticals Inc shares closed today 20.0% higher than it did at the end of yesterday. The stock is currently down ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips NRx Pharmaceuticals (NASDAQ:NRXP) stock gained 50% last Friday ...
What happened Shares of NRx Pharmaceuticals (NASDAQ: NRXP) surged on Monday after the healthcare company released promising ...
NRx Pharmaceuticals Inc. (NRXP) is priced at $6.75 after the most recent trading session. At the very opening of the session, the stock price was $4.62 and reached a high price of $8.89, prior to ...
NRx Pharma's COVID-19 Vaccine Displays Effectiveness Against Delta Variant in Phase 2 Clinical Trial
Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute ...
NRx Pharmaceuticals Inc. (NASDAQ:NRXP) concluded the trading at $5.94 on Wednesday, December 01 with a fall of -11.08% from its closing price on previous day. Taking a look at stock we notice that its ...
NRx Pharmaceuticals Inc. (NASDAQ:NRXP) has a beta value of 0.25 and has seen 73.88 million shares traded in the last trading ...
During the recent session, NRx Pharmaceuticals Inc. (NASDAQ:NRXP)’s traded shares were 0.57 million, with the beta value of ...
NRx Pharmaceuticals Inc. soared after an analysis showed that its drug helped severely ill patients who had been treated with ...
Insiders at NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) must be relieved they sold stock as market valuation descends to US$268m
Insiders seem to have made the most of their holdings by selling US$83k worth of NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) stock at an average sell price of US$13.11 during the past year. The company’s ...
NRx Pharmaceuticals Inc. (NASDAQ:NRXP) traded at $6.75 at close of the session on Friday, 11/26/21, made an upward move of 50.00% on its previous day’s price. Looking at the stock we see that its ...
By Chris Wack NRx Pharmaceuticals Inc. shares were up 18%, to $7.96, after the company said it has completed an analysis to identify clinical evidence ...